Clinical Trials Browser

Phase 1/2 × Tissue Plasminogen Activator × Clear all

NCT00086723 2012-06-11

In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer

Phase 1/2 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific